Doreen M. Hallman

1.1k citations
8 papers · 688 indexed · 1 hit paper · h-index 6
Topics
Lymphoma Diagnosis and Treatment (7 papers)Lung Cancer Treatments and Mutations (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)

In The Last Decade

Doreen M. Hallman

8 papers receiving 677 citations

Hit Papers

Randomized trial of bendamustine-rituximab or R-CHOP/R-CV...20142026201820222014100200300400

Peers

Doreen M. Hallman
Comparison fields: 5 of 37
  • Pathology and Forensic Medicine 583
  • Oncology 517
  • Genetics 308
  • Neurology 103
  • Pulmonary and Respiratory Medicine 71
Replace C. Jonas with:
C. Jonas United States
I Tabah France
Alden A. Moccia Switzerland
Baha Alkuzweny United States
Jesse G. Dixon United States
Andrej Vranovský Slovakia
Suguru Fukuhara Japan
Manfred Welslau Germany
Fiona Miall United Kingdom
Yiu‐Lam Kwan Australia
Doreen M. Hallman relative to C. Jonas United States C. Jonas's profile →
Citations per field
00.5×11.5×
C. Jonas · 1×
Citations per year

Countries citing papers authored by Doreen M. Hallman

Since Specialization
Citations

This map shows the geographic impact of Doreen M. Hallman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen M. Hallman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen M. Hallman more than expected).

Fields of papers citing papers by Doreen M. Hallman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen M. Hallman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen M. Hallman. The network helps show where Doreen M. Hallman may publish in the future.

Co-authorship network of co-authors of Doreen M. Hallman

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen M. Hallman. A scholar is included among the top collaborators of Doreen M. Hallman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen M. Hallman. Doreen M. Hallman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 166
2 10
3 9
4 13
5
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT studybreakdown →
419
6 3
7 2
8 66

About Doreen M. Hallman

Doreen M. Hallman is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine, having authored 8 papers that have together received 688 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (583 citations), Genetics (308 citations) and Oncology (517 citations). Doreen M. Hallman has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include David MacDonald, Ian W. Flinn, Samar Issa, Richard van der Jagt, John M. Burke, Peter Wood, Kathryn S. Kolibaba, Tim E. Hawkins, David Simpson and Brad S. Kahl. Their work appears in journals such as Journal of Clinical Oncology, Blood and Hematological Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026